A2LA has been granted ASCA (Accreditation Scheme for Conformity Assessment) Recognition by the FDA, making it among the first accreditation bodies accepted as a participant in the ASCA Pilot program. The ASCA Pilot is a cooperative program that relies on participation from accreditation bodies, testing laboratories, medical device manufacturers and FDA staff. Accreditation bodies like A2LA that meet the FDA’s requirements for this new program are granted ASCA Recognition, enabling them to assess testing laboratories seeking ASCA accreditation to perform premarket testing for medical device companies.
A2LA is pleased to announce the accreditation of ECC Test Lab to ISO/IEC 17025:2017 for cannabis testing. East Coast Cannalytics (dba ECC Test Lab), based in Blacksburg, VA, is the first cannabis testing laboratory accredited to the standard in the state by A2LA.
On August 18th, 2020 A2LA granted ISO/IEC 17025:2017 accreditation to MEMP Service Corporation (Molecular Environmental Monitoring Provider). MEMP Service Corp. sought accreditation to this standard as part of the development of their cutting-edge new mobile molecular environmental monitoring services. This mobile biosurveilance solution allows MEMP to deploy an on-site molecular testing laboratory to any location and provide test results in four hours or less for a wide variety of microbial pathogens and other molecular targets.
A2LA is pleased to announce the accreditation of Trichome Analytical to ISO/IEC 17025:2017 for cannabis testing. Trichome, based in Mount Laurel, NJ, is the first cannabis testing laboratory accredited to the standard in the state.
ALS, global provider of laboratory testing services, has recently expanded their scope of accreditation to include their newest food laboratory under the American Association for Laboratory Accreditation (A2LA) satellite program. This new ALS laboratory is a greenfield startup laboratory in Houston, Texas that sought accreditation by A2LA for testing.
A2LA is pleased to announce the accreditation of Viridis Laboratories to ISO/IEC 17025:2017 for cannabis testing. Viridis, based in Lansing, MI, is A2LA’s first cannabis testing laboratory accredited in the State of Michigan.
On August 4th 2020 A2LA was granted approval to perform assessments on behalf of The New Hampshire Environmental Laboratory Accreditation Program (NH ELAP), which provides accreditation for environmental laboratories, both in New Hampshire and out-of-state. NH ELAP accreditation ensures that the results of covered tests, analyses, and measurements are sufficiently accurate, precise and consistent. This is the eighth state environmental accreditation program for which A2LA is now authorized to provide assessments.
A2LA has extended their signatory status with the International Laboratory Accreditation Cooperation (ILAC) mutual recognition arrangement (MRA) to include reference material producers (RMPs) under the standard ISO 17034. This means that A2LA’s ISO 17034 accreditation program is now internationally recognized and has been confirmed to meet ILAC’s globally accepted criteria. A2LA has been a signatory of the ILAC MRA since 2000 and this extension was finalized on July 23, 2020. The Reference Materials Producers Accreditation Program is the sixth A2LA accreditation program recognized by ILAC.
On May 21st, the A2LA-accredited laboratory Source Molecular Corporation (SMC) introduced testing services for SARS-CoV-2, the virus that causes COVID-19, on wastewater, air, and surfaces. They are the first A2LA-accredited laboratory to conduct this type of SARS-CoV-2 testing, which is covered by their flexible scope of accreditation. SMC, a Florida-based molecular testing lab, provides innovative technology to help solve pathogenic water, air and surface pollution problems through source tracking, genetic and molecular techniques, and test kits. These new tests, developed to help address the spread of coronavirus, are a timely complement to their longstanding mission. A2LA updated SMC’s scope in 2019 when their accreditation was renewed, which enabled them to add these new tests in response to the ongoing global pandemic.
ALS, an international provider of laboratory services headquartered in Australia, has recently expanded the scope of accreditation at their largest US laboratory to include a test for the detection of the novel coronavirus on surfaces. This ALS laboratory is among the first laboratories to be accredited by A2LA for this kind of testing. With many US states beginning to “reopen” the need to test frequently contacted surfaces for the presence of SARS-CoV-2, the virus that causes COVID-19, is becoming an even more crucial part of efforts to curtail the spread of the disease. A2LA has been committing extra resources to process and evaluate scope expansions for tests such as these thoroughly and expediently to support the scientific community in fighting this pandemic. Accreditation by an impartial, third-party accreditation body such as A2LA is a critical indicator of the quality of newly produced tests and methods.